Dr. Tingting Zhang
Dr. Tingting Zhang is an executive at Kangmei Pharmaceuticals, a leading Chinese pharmaceutical company based in Shenzhen. Dr. Zhang receive her undergraduate education from Fudan University in Shanghai, and her doctorate degree from Columbia University in the city of New York.
In 2001, she started at Lawrence Berkeley National Lab where her work received a commendation from DARPA in 2005. She then joined Roche and then Eli Lilly to lead computational and decision analytics for cancer,immunological and infectious diseases. In 2011, she transitioned from drug research and development to personalized healthcare and in 2015 returned to China to lead a personalized cancer therapy management platform invested by Kangmei Pharmaceuticals.